Clinical Trials Browser

Phase 1 × Has results × Amyloidosis × Clear all

NCT02603172 2019-09-23

A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis

Phase 1 Terminated

23 enrolled 25 charts

Immunoglobulin Light-chain Amyloidosis, Amyloidosis